Lipid lowering drugs in diabetes: Absolute risk reduction is what counts [2]

British Medical Journal

Volumn 332, Issue 7552, 2006, Pages 1272-

  Lewis, L S ^a  

^a Surgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LETTER; MEDICAL LITERATURE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; HYPERLIPIDEMIA; NOTE; RISK FACTOR;

ANTILIPEMIC AGENT;

ANTILIPEMIC AGENTS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERLIPIDEMIAS; RISK FACTORS;

EID: 33744973347     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Costa J, Borges M, David C, Carneiro AV. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ 2006;332:1115-24. (13 May.)